Our story

“I started Ophelia with the mission of making evidence-based addiction treatment universally accessible. Let’s make it easier to choose doctors than drug dealers.”
Zack Gray
Co-Founder & CEO
Person sitting on grassy hill watching sunset with stepping stones

Treatment isn’t one size fits all

Our mission is to provide the best opioid addiction treatment without the baggage of rehab. We're driven by science and committed to privacy. Above all, we believe in recommendations, not orders.

What we believe

01

There’s a proven treatment for opioid addiction, and it’s easier than most people think

Medication-assisted treatment reduces overdoses by 75%, and it’s covered by insurance. It’s just too hard to get. Ophelia is here to change that.

02

Recovery on your own terms

Rehab requires putting your life on hold, leaving your environment, and living somewhere else for months. Ophelia offers a different kind of solution.

03

Patients are the experts on themselves

We won’t force you to do anything you don’t want. Quite the opposite. You’re the expert of your own life. We advocate harm reduction because everyone deserves the right to feel safe.

Ophelia’s founders

Image of Zack Gray

Zack Gray

Co-Founder and CEO

Zack started Ophelia after losing someone he loved to an opioid overdose.

He’s a Y Combinator-backed entrepreneur, Columbia University-funded research scholar, and a Wharton MBA graduation speaker. Previously, Zack led customer acquisition for a residential solar startup, which he helped grow to $30M in revenue. He studied astrophysics and philosophy at Columbia University and received his MBA from The Wharton School.

Image of Mattan Griffel

Mattan Griffel

Co-Founder, President, and COO

Mattan helps scale the technology and processes that allow the company to grow.

He’s an award-winning faculty member at Columbia Business School, and a two-time Y Combinator-backed entrepreneur. He’s an Innovation Fellow at the Lang Center for Entrepreneurship, and was selected as one of Forbes’ 30 Under 30 in Education. Mattan studied Philosophy and Finance at New York University and wrote his thesis on the metaphysics of consciousness.

5-star icon

What our patients are saying

"
I was hesitant at first, but it has been nothing but a positive experience. My physician has been supportive and non-judgemental. She listens and genuinely cares.
"
Read more reviews

Designed by world-leading medical experts

Image of Dr. Arthur Robin Williams

Dr. Arthur Robin Williams

Chief Medical Officer

Dr. Arthur Robin Williams is a codesigner of Ophelia and brings a wealth of knowledge on substance use disorders. Currently, he’s an Assistant Professor of Clinical Psychiatry at Columbia University Medical Center, and a Research Scientist at New York State Psychiatric Institute supported with NIH, SAMHSA, and CDC funding. He has served as an expert speaker or consultant to the NIH HEAL Initiative, the National Quality Forum, and the American Psychiatric Association to aide quality measure development efforts for the opioid crisis under the OUD Cascade of Care framework.

Image of Dr. Adam Bisaga

Dr. Adam Bisaga

Senior Medical Director

Dr. Adam Bisaga codesigned Ophelia alongside Dr. Arthur Williams in order to help patients struggling with opioid addiction. He is an academic addiction psychiatrist and NIH funded researcher developing novel approaches to treat substance use disorders. Dr. Bisaga is a member of the UN Office of Drugs and Crime Expert Panel and has worked with UN agencies internationally training providers and developing treatment guidances.

Ophelia in the news

Using telemedicine to treat opioid addiction

Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.

Read full story

What you need to know about joining a virtual accelerator now

Michael Seibel from Y Combinator has a message for entrepreneurs: The pandemic hasn't scared off investors.

Read full story

Why venture capital doesn’t build the things we really need

The funding model that made Silicon Valley a global hub excels at creating a certain kind of innovation—but the pandemic has exposed its broader failures.

Read full story

Rehab 2.0: YC-backed Ophelia raises $2.7 million to help people quit opioids without the burden and cost of rehab

Ophelia wants to offer individuals who struggle with opioid addiction medication-assisted treatment (MAT) through its telemedicine platform.

Read full story

Ophelia Health gets menlo ventures backing for opioid-addiction therapy

Startup uses telemedicine to provide medication, counseling for opioid addiction.

Read full story

Using telemedicine to treat opioid addiction

Getting medication long meant seeing a licensed provider. Now a strategy for evading Covid-19 makes treatment available via the web.

Read full story

What you need to know about joining a virtual accelerator now

Michael Seibel from Y Combinator has a message for entrepreneurs: The pandemic hasn't scared off investors.

Read full story

Why venture capital doesn’t build the things we really need

The funding model that made Silicon Valley a global hub excels at creating a certain kind of innovation—but the pandemic has exposed its broader failures.

Read full story

Rehab 2.0: YC-backed Ophelia raises $2.7 million to help people quit opioids without the burden and cost of rehab

Ophelia wants to offer individuals who struggle with opioid addiction medication-assisted treatment (MAT) through its telemedicine platform.

Read full story

Ophelia Health gets menlo ventures backing for opioid-addiction therapy

Startup uses telemedicine to provide medication, counseling for opioid addiction.

Read full story

Treatment that works is right at your fingertips.

Get started